These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16156375)

  • 1. Glucocorticoid hypertension due to the use of bleaching skin cream, a case report.
    Bwomda P; Sermijn E; Lacor P; Velkeniers B
    Acta Clin Belg; 2005; 60(3):146-9. PubMed ID: 16156375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pursuit of beauty.
    Druce M; Goldstone AP; Tan TM; Meeran K
    Lancet; 2008 Feb; 371(9612):596. PubMed ID: 18280330
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolonged childhood Cushing's syndrome secondary to intralesional triamcinolone acetonide.
    Teelucksingh S; Balkaran B; Ganeshmoorthi A; Arthur P
    Ann Trop Paediatr; 2002 Mar; 22(1):89-91. PubMed ID: 11926057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cushing syndrome secondary to topical glucocorticoids.
    Joe EK
    Dermatol Online J; 2003 Oct; 9(4):16. PubMed ID: 14594589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How do glucocorticoids cause hypertension: role of nitric oxide deficiency, oxidative stress, and eicosanoids.
    Ong SL; Whitworth JA
    Endocrinol Metab Clin North Am; 2011 Jun; 40(2):393-407, ix. PubMed ID: 21565674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iatrogenic Cushing Syndrome And Hypertension In An Infant Girl Due To Use Of Nappy Rash Cream Containing A Potent Topical Steroid.
    Gillani S; Danish BA; Muhammad Shah SF; Hussain F; Aziz F; Iqbal A
    J Ayub Med Coll Abbottabad; 2020; 32(1):152. PubMed ID: 32468778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug reactions to various topical glucocorticosteroids: quantitative aspects.
    Höhler T; Wörz K; Himmler V
    Curr Probl Dermatol; 1993; 21():180-5. PubMed ID: 8299371
    [No Abstract]   [Full Text] [Related]  

  • 8. Minimal change disease following exposure to mercury-containing skin lightening cream.
    Tang HL; Chu KH; Mak YF; Lee W; Cheuk A; Yim KF; Fung KS; Chan HW; Tong KL
    Hong Kong Med J; 2006 Aug; 12(4):316-8. PubMed ID: 16912361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous Cushing's syndrome and glucocorticoid withdrawal.
    Hopkins RL; Leinung MC
    Endocrinol Metab Clin North Am; 2005 Jun; 34(2):371-84, ix. PubMed ID: 15850848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An infantile Cushing syndrome due to misuse of topical steroid.
    Siklar Z; Bostanci I; Atli O; Dallar Y
    Pediatr Dermatol; 2004; 21(5):561-3. PubMed ID: 15461763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid excess syndromes causing hypertension.
    Krakoff LR
    Cardiol Clin; 1988 Nov; 6(4):537-45. PubMed ID: 3067845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cushing syndrome from percutaneous absorption of 1% hydrocortisone ointment in Netherton syndrome.
    Halverstam CP; Vachharajani A; Mallory SB
    Pediatr Dermatol; 2007; 24(1):42-5. PubMed ID: 17300648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complications and side effects of hormonal therapy in children].
    Al'bitskaia TB; Balashova LI; Khomiakova VI
    Vopr Okhr Materin Det; 1966 Jun; 11(6):56-8. PubMed ID: 4294160
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms of glucocorticoid-induced hypertension.
    Whitworth JA
    Kidney Int; 1987 May; 31(5):1213-24. PubMed ID: 3298796
    [No Abstract]   [Full Text] [Related]  

  • 15. Iatrogenic Cushing's syndrome in children presenting at Children's Hospital Lahore using nappy rash ointments.
    Sattar H; Manzoor J; Mirza L; Sheikh AM; Butt TA
    J Pak Med Assoc; 2015 May; 65(5):463-6. PubMed ID: 26028377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A young African woman with hyperglycaemia.
    Morton A; Menon A; O'Moore-Sullivan T
    Aust Fam Physician; 2016 Apr; 45(4):206-7. PubMed ID: 27052137
    [No Abstract]   [Full Text] [Related]  

  • 17. Cushing's syndrome induced by high-potency topical corticosteroids.
    Demirsoy EO; Bilen N; Aktürk AS; Kocaoğlu Ö; Mutlu GY
    Int J Dermatol; 2014 Jan; 53(1):e20-2. PubMed ID: 22591336
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cushing syndrome because of herbal supplement].
    Krul-Poel YHM; Bovee TFH; Fransen EJF; Berentsen R; Deckers MML; de Bie P
    Ned Tijdschr Geneeskd; 2024 Jun; 168():. PubMed ID: 38989679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous hypopigmentation following a posterior sub-tenon triamcinolone injection.
    Gallardo MJ; Johnson DA
    Am J Ophthalmol; 2004 Apr; 137(4):779-80. PubMed ID: 15059734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin lightening cream induced dermatitis and atrophy.
    Bremmer M; Gardner J; Driscoll M
    Dermatol Online J; 2011 Mar; 17(3):13. PubMed ID: 21426879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.